Neutropenia risk factors: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(One intermediate revision by the same user not shown)
Line 4: Line 4:


==Overview==
==Overview==
At-risk populations include those undergoing cytotoxic chemotherapy or other myelosuppressive medications, however a benign form of mild neutropenia is commonly identified in certain ethnicities (blacks, Yemenites, West Indians, Arab Jordanians). This latter group rarely develops complications from their neutropenia.
At-risk populations include those undergoing [[cytotoxic]] [[chemotherapy]] or other myelosuppressive medications, however a benign form of mild [[neutropenia]] is commonly identified in certain ethnicities (blacks, Yemenites, West Indians, Arab Jordanians). This latter group rarely develops complications from their neutropenia.


==Risk Factors==
==Risk Factors==
*Medications
* [[Medications]]<ref name="PMID17142169">{{cite journal |author=Andrès E, Zimmer J, Affenberger S, Federici L, Alt M, Maloisel F. |title=Idiosyncratic drug-induced agranulocytosis: Update of an old disorder. |journal=Eur J Intern Med. |volume=17|issue=8 |pages=529-35 |year=2006|pmid 17142169|doi=|url=https://www.ncbi.nlm.nih.gov/pubmed/17142169}}</ref>
*Hematologic malignancies
* [[List of chemotherapeutic agents#Cytotoxic Chemotherapy|Cytotoxic chemotherapy]]
*Autoimmune disorders
* Hematologic malignancies
*Infections
* [[Autoimmune disorders]]
*Black, Yemenite, West Indian, or Arab Jordanian ethnicity
* Infections
* [[Hemodialysis]]
* [[Radiation therapy]]
* [[avitaminosis|Vitamin deficiencies e.g. folate, Vitamin B12]]
* Black, Yemenite, West Indian, or Arab Jordanian ethnicity


==References==
==References==

Latest revision as of 00:18, 17 November 2016

Neutropenia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Neutropenia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Neutropenia risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Neutropenia risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Neutropenia risk factors

on Neutropenia risk factors

Neutropenia risk factors in the news

Blogs on Neutropenia risk factors

Directions to Hospitals Treating Neutropenia

Risk calculators and risk factors for Neutropenia risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Daniel A. Gerber, M.D. [2]

Overview

At-risk populations include those undergoing cytotoxic chemotherapy or other myelosuppressive medications, however a benign form of mild neutropenia is commonly identified in certain ethnicities (blacks, Yemenites, West Indians, Arab Jordanians). This latter group rarely develops complications from their neutropenia.

Risk Factors

References

  1. Andrès E, Zimmer J, Affenberger S, Federici L, Alt M, Maloisel F. (2006). "Idiosyncratic drug-induced agranulocytosis: Update of an old disorder". Eur J Intern Med. 17 (8): 529–35. Text "pmid 17142169" ignored (help)

Template:WH Template:WS